SYNTHOCYTES

Welcome to the Brand page for “SYNTHOCYTES”, which is offered here for Pharmaceutical preparations and substances for the treatment of thrombocytopenia; drug delivery agents, microcapsules for introduction to the body of drugs, genes and other therapeutic products or diagnostic agents for treatment of thrombocytopenia; pharmaceutical preparations and substances for use in delivery of drugs, genes and other therapeutic products or diagnostic agents to humans for treatment of thrombocytopenia; pharmaceutical preparations for the treatment of internal bleeding; platelet substitutes for human use;.

Its status is currently believed to be active. Its class is unavailable. “SYNTHOCYTES” is believed to be currently owned by “ProFibrix B.V.”


Owner:
PROFIBRIX B.V.
Owner Details
Description:
PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT OF THROMBOCYTOPENIA; DRUG DELIVERY AGENTS, MICROCAPSULES FOR INTRODUCTION TO THE BODY OF DRUGS, GENES AND OTHER THERAPEUTIC PRODUCTS OR DIAGNOSTIC AGENTS FOR TREATMENT OF THROMBOCYTOPENIA; PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR USE IN DELIVERY OF DRUGS, GENES AND OTHER THERAPEUTIC PRODUCTS OR DIAGNOSTIC AGENTS TO HUMANS FOR TREATMENT OF THROMBOCYTOPENIA; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF INTERNAL BLEEDING; PLATELET SUBSTITUTES FOR HUMAN USE;
Categories: PHARMACEUTICAL PREPARATIONS SUBSTANCES